Is It Time to Take a Different Approach to Screening People at High Risk for Type 1 Diabetes?

por Boyko, Edward J., Palmer, Jerry P.
Publicado 2009

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

por Lachin, John M., McGee, Paula, Palmer, Jerry P.
Publicado 2014

Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies

por Beam, Craig A., Gitelman, Stephen E., Palmer, Jerry P.
Publicado 2014

Growth and Hope after loss: How TAPS facilitates posttraumatic growth in those grieving military deaths

por Moore, Melinda, Palmer, Jerry K., Cerel, Julie, Ruocco, Kim
Publicado 2022

Impact of Islet Autoimmunity on the Progressive β-Cell Functional Decline in Type 2 Diabetes

por Brooks-Worrell, Barbara M., Boyko, Edward J., Palmer, Jerry P.
Publicado 2014

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Palmer, Jerry P.
Publicado 2012

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients

por Brooks-Worrell, Barbara M., Reichow, Jessica L., Goel, Amit, Ismail, Heba, Palmer, Jerry P.
Publicado 2011

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Matheson, Della, Skyler, Jay S.
Publicado 2008

Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes

por Lachin, John M., McGee, Paula L., Greenbaum, Carla J., Palmer, Jerry, Pescovitz, Mark D., Gottlieb, Peter, Skyler, Jay
Publicado 2011

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Palmer, Jerry P., Rafkin, Lisa E., Krischer, Jeffrey P., Cuthbertson, David, Greenbaum, Carla J., Eisenbarth, George, Skyler, Jay S.
Publicado 2010

Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes

por Brooks-Worrell, Barbara M., Iyer, Dinakar, Coraza, Ivonne, Hampe, Christiane S., Nalini, Ramaswami, Ozer, Kerem, Narla, Radhika, Palmer, Jerry P., Balasubramanyam, Ashok
Publicado 2013

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants

por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P., Krischer, Jeffrey P., Cuthbertson, David, Yu, Liping, Schatz, Desmond A., Orban, Tihamer, Eisenbarth, George
Publicado 2011

Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

por Orban, Tihamer, Sosenko, Jay M., Cuthbertson, David, Krischer, Jeffrey P., Skyler, Jay S., Jackson, Richard, Yu, Liping, Palmer, Jerry P., Schatz, Desmond, Eisenbarth, George
Publicado 2009

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Palmer, Jerry P., Rafkin-Mervis, Lisa, Krischer, Jeffrey P., Cuthbertson, David, Mahon, Jeffery, Greenbaum, Carla J., Cowie, Catherine C., Skyler, Jay S.
Publicado 2009

Validity and Reproducibility of Measurement of Islet Autoreactivity by T-Cell Assays in Subjects With Early Type 1 Diabetes

por Herold, Kevan C., Brooks-Worrell, Barbara, Palmer, Jerry, Dosch, H. Michael, Peakman, Mark, Gottlieb, Peter, Reijonen, Helena, Arif, Sefina, Spain, Lisa M., Thompson, Clinton, Lachin, John M.
Publicado 2009

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)

por Sosenko, Jay M., Skyler, Jay S., Krischer, Jeffrey P., Greenbaum, Carla J., Mahon, Jeffrey, Rafkin, Lisa E., Cuthbertson, David, Cowie, Catherine, Herold, Kevan, Eisenbarth, George, Palmer, Jerry P.
Publicado 2010

The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients

por Sosenko, Jay M., Skyler, Jay S., Palmer, Jerry P., Krischer, Jeffrey P., Yu, Liping, Mahon, Jeffrey, Beam, Craig A., Boulware, David C., Rafkin, Lisa, Schatz, Desmond, Eisenbarth, George
Publicado 2013

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

por Sosenko, Jay M., Skyler, Jay S., Beam, Craig A., Krischer, Jeffrey P., Greenbaum, Carla J., Mahon, Jeffrey, Rafkin, Lisa E., Matheson, Della, Herold, Kevan C., Palmer, Jerry P.
Publicado 2013

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1) and TrialNet Oral...

por Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Schatz, Desmond A., Haller, Michael J., Pugliese, Alberto, Cleves, Mario, Geyer, Susan, Rafkin, Lisa E., Matheson, Della, Palmer, Jerry P.
Publicado 2020